NCT00163605已完成2 期
A Prospective Clinical Study to Evaluate the Performance and Safety of the Bone Substitute MBCP-FS in Maxillary Sinus Lift Procedures
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 86
- 试验地点
- 6
研究概览
简要总结
The purpose of this study is to evaluate the performance and to monitor the safety of the bone substitute Macroporous Biphasic Calcium Phosphate-Fibrin Sealant Vapor Heated Solvent/Detergent Treated 4 IU/ML Thrombin (MBCP-FS) in Sinus Lift Procedures . This study will be conducted in two parts: part A evaluates safety and performance of MBCP-FS in bone regeneration i.e. the amount of new bone that is formed and its suitability for dental implant placement. Part B is designed to evaluate long-term safety and performance of the product, i.e. whether the newly-formed bone is suitable to retain implants.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- •Previous or coeval major surgical intervention in the targeted area, or major surgical intervention in the targeted area planned within the next 18 months (like Caldwell Luc) (minor interventions like surgical tooth extraction or root tip resections are allowed)
- •Surgical tooth extraction in the targeted area less than three months before the SLP
- •Maxillary and sinus disorders including: acute sinusitis, chronic sinus pathology, retained root tips, polyps, tumors, and cysts in antral cavity or odontogenic cysts, alveolar scar ablation
- •Major occlusal disturbance, like severe bruxism
- •Uncontrolled* periodontal disease
- •An inadequate interarch distance requiring an oppositional graft
- •Immune system disorders, immunodeficiency or immunosuppression
- •Known coagulation disorder
- •Uncontrolled* diabetes mellitus
- •Severe hyperparathyroidism
- •Receiving long-term anti-inflammatory treatment with NSAIDs or corticosteroids
- •Chemotherapy current or in the last three months
- •Having undergone maxillary radiation therapy
- •Known hypersensitivity to aprotinin or to other components of the investigational product
- •Abuse of alcohol or drugs or tobacco consumption of more than 5 cigarettes per day at study start
- •Non-compliant for future dental hygiene
- •Severely compromised physical and psychological health, that in the investigators opinion will affect patient compliance
- •Any contra-indications to the use of MBCP, which are defined as osteomyelitis, degenerative bone disease or necrosis of the recipient site
- •Concurrently participating in another clinical trial and having received another investigational drug or device within the last 30 days
- •Pregnant or lactating, or intending to become pregnant during the study period
- •Uncontrolled = not treated or not stabilized after treatment
研究者
研究点 (6)
Loading locations...
相似试验
已完成
不适用
Clinical Study to Evaluate the Catheter Robotics Amigo for Performing Right-Sided Electrophysiology Mapping StudiesVentricular TachycardiaAtrial FlutterNCT01139814Catheter Robotics, Inc.181
招募中
不适用
Study Protocol to Evaluate Clinical and Imaging Results of Knee Fresh Osteochondral AllograftsOsteochondral DefectNCT04236492Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau40
Unknown
不适用
Prospective Study of Safety and Efficacy of InQu® Bone Graft Extender in Lumbar Interbody Fusion SurgeryIntervertebral Disc DegenerationNCT02400762ISTO Technologies, Inc.130
已完成
不适用
Safety and Performance of a GLOBAL Mapping and Ablation Device for the Treatment of Atrial Fibrillation (GLOBAL-AF)Atrial FibrillationNCT02168972Kardium Inc.60
Unknown
不适用
A Pilot Study of the InterCushion Disc Nucleus Prosthesis (DNP) in Patients Receiving DiscectomyDisk, HerniatedNCT01652053Vertebral Technologies, Inc.100